Iterum Therapeutics (ITRM) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ITRM Stock Alerts $1.58 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 2 at 10:27 AMIterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 30 at 6:45 PMQ4 2023 Iterum Therapeutics PLC Earnings Callfinance.yahoo.com - March 29 at 2:40 AMIterum Therapeutics PLC: Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 28 at 11:34 AMIterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 28 at 7:00 AMIterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024globenewswire.com - March 21 at 4:30 PMIterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chatglobenewswire.com - March 15 at 8:00 AMEQS-News: Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovationsmarkets.businessinsider.com - March 12 at 10:42 AMIterum Therapeutics Provides Business Updatefinance.yahoo.com - March 6 at 7:38 PMIterum Therapeutics PLC (ITRM)investing.com - February 28 at 7:36 AMIterum Therapeutics (ITRM) Price Target Increased by 550.00% to 6.63msn.com - February 24 at 2:19 AMSteven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLCfinance.yahoo.com - February 1 at 4:09 PMIterum Shareholders Reject Board’s Share Issuance Proposalmsn.com - February 1 at 12:05 AMIterum Therapeutics Announces Triumph in Phase 3 uUTI Trialmsn.com - January 31 at 7:49 AMWhy Iterum Therapeutics Stock Is Trending Todaymsn.com - January 30 at 4:48 PMIterum meets main goal in late trial for uUTI treatment with oral sulopenemmsn.com - January 30 at 4:48 PMIterum Therapeutics's Late-stage REASSURE Trial Successfully Met Primary Endpointmarkets.businessinsider.com - January 30 at 4:48 PMIterum Therapeutics Says UTI Drug Trial Met Primary Endpointmarketwatch.com - January 30 at 9:45 AMIterum Therapeutics Shares Surge on Positive UTI Drug Trial Resultsmarketwatch.com - January 30 at 9:45 AMIterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infectionsfinance.yahoo.com - January 30 at 9:45 AMmarketbeat.com - January 30 at 6:58 AMInsiders Buying Iterum Therapeutics And 3 Other Stocks Under $3msn.com - December 28 at 1:31 PMIterum Therapeutics director discloses purchase of 20K sharesmsn.com - November 29 at 1:43 AMIterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 15 at 2:19 PMQ3 2023 Iterum Therapeutics PLC Earnings Callfinance.yahoo.com - November 15 at 12:49 AMIterum Therapeutics PLC: Iterum Therapeutics Reports Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 14 at 9:47 AMIterum Therapeutics GAAP EPS of -$0.30msn.com - November 14 at 9:47 AMRecap: Iterum Therapeutics Q3 Earningsbenzinga.com - November 14 at 9:47 AMIterum Therapeutics Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 9:47 AMIterum Therapeutics Q3 2023 Earnings Previewmsn.com - November 13 at 1:59 PMEarnings Outlook For Iterum Therapeuticsbenzinga.com - November 13 at 1:59 PMIterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023finance.yahoo.com - November 7 at 9:46 AMIterum Therapeutics PLC ITRMmorningstar.com - November 5 at 6:59 PMIterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infectionsfinance.yahoo.com - October 24 at 1:57 PMIterum Therapeutics to Present Data at IDWeek 2023finance.yahoo.com - October 12 at 12:00 PMQ2 2023 Iterum Therapeutics PLC Earnings Callfinance.yahoo.com - August 12 at 12:15 AMIterum Therapeutics PLC: Iterum Therapeutics Reports Second Quarter 2023 Financial Resultsfinanznachrichten.de - August 11 at 2:15 PMIterum Therapeutics Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 11 at 2:15 PMIterum Therapeutics's Earnings: A Previewbenzinga.com - August 10 at 1:09 PMIterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023finance.yahoo.com - August 4 at 9:19 PMITRM - Iterum Therapeutics plcfinance.yahoo.com - July 11 at 5:56 PMIterum Therapeutics to Present Data at ASM Microbe 2023finance.yahoo.com - June 12 at 7:30 PMIterum Therapeutics PLC: Iterum Therapeutics Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - May 12 at 10:53 AMIterum Therapeutics Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 12 at 10:53 AMNektar Therapeutics (NKTR) Q1 Earnings & Revenues Beatfinance.yahoo.com - May 10 at 1:21 PM8-K: Iterum Therapeutics plcmarketwatch.com - May 5 at 7:32 PMIterum Therapeutics Presents Scientific Posters at ECCMID 2023 Highlighting Application of Desirability of Outcomes Ranking (DOOR) to two Registration Trialsfinance.yahoo.com - April 20 at 6:08 PMAll You Need to Know About Iterum Therapeutics PLC (ITRM) Rating Upgrade to Strong Buyfinance.yahoo.com - April 13 at 3:38 PMIterum Therapeutics plc (ITRM) Q4 2022 Earnings Call Transcriptseekingalpha.com - March 18 at 3:41 PMIterum Therapeutics plc (NASDAQ:ITRM) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 18 at 10:40 AM Get Iterum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry ITRM Media Mentions By Week ITRM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ITRM News Sentiment▼0.000.44▲Average Medical News Sentiment ITRM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ITRM Articles This Week▼00▲ITRM Articles Average Week Get Iterum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DURECT News Eyenovia News Qilian International Holding Group News Lipocine News Vaxxinity News Sol-Gel Technologies News Forte Biosciences News Unity Biotechnology News Sensei Biotherapeutics News Acasti Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ITRM) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
